POLICY: FOR TRAVELERS COMING FROM CDC LEVEL 3 COUNTRIES AND ALL OTHER (NON-CDC LEVEL 3) OVERSEAS LOCATIONS
Last modified Feb. 28 at 2 p.m.
FOR TRAVELERS COMING FROM CDC LEVEL 3 COUNTRIES
LBNL is implementing a 14-day self-isolation policy for asymptomatic travelers coming to the Lab from CDC Level 3 countries, currently China, South Korea, Italy, and Iran. Asymptomatic travelers are those who do not exhibit symptoms compatible with COVID-19 infection. If the incoming traveler becomes symptomatic, they should contact a healthcare provider.
This policy applies to any individual (employee, affiliate, user, or visitor) who has traveled from or through a CDC Level 3 country who has the intention of accessing the LBNL main site or satellite locations. These individuals are asked to not access LBNL facilities until 14 days have passed since departure from any CDC Level 3 country.
Asymptomatic travelers coming from a CDC Level 3 country should engage in self-monitoring, as defined by the CDC “Interim US Guidance for Risk Assessment and Public Health Management of Persons with Potential Coronavirus Disease 2019 (COVID-19) Exposure in Travel-associated or Community Settings,” dated February 8, 2020. Per this definition:
Self-monitoring means people should monitor themselves for fever by taking their temperatures twice a day and remain alert for a cough or difficulty breathing.
FOR ALL TRAVELERS COMING FROM ALL OTHER (NON-CDC LEVEL 3) OVERSEAS LOCATIONS
Travelers coming from non-CDC Level 3 countries with symptoms compatible with COVID-19 infection should reduce exposure through self-isolation, and need to contact their health care provider. Individuals desiring to be tested or seeking guidance on when to return to work should also contact their health care provider.